Sharma Mani bought AZN

August 8, 2026 · Form 4 insider transaction

Sharma Mani bought 20.233 shares of AstraZeneca PLC at $160.57 per share, a transaction worth $3.2K. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 34 days after the transaction.

Direction
Acquired (buy-side)
Shares
20.233
Price
$160.57
Total value
$3.2K
Role—
SecurityOrdinary Shares
Transaction codeP: Open-market purchase
Transaction dateAugust 8, 2026
Filing dateSeptember 11, 2026
Shares owned after19,288
OwnershipDirect
10b5-1 planNo
AmendedNo

Footnotes

Represents the automatic reinvestment of dividends accrued during the holding period of the Issuer's Restricted Share Plan, at a price of GBP118.96, which has been converted from British pounds sterling to United States dollars at a conversion rate of GBP1.0000 to $1.3498 on August 7, 2026 as published by the Board of Governors of the Federal Reserve System. The dividend equivalent units will vest and be released to the Officer at the end of the three year holding period.

View the original Form 4 on SEC EDGAR